Design of Leucine-Rich Repeat Kinase 2 (LRRK2) Inhibitors Using a Crystallographic Surrogate Derived from Checkpoint Kinase 1 (Chk1)
Williamson, D. S. et al., J. Med. Chem. 2017, 60, 8945–8962
< Back to all news
Williamson, D. S. et al., J. Med. Chem. 2017, 60, 8945–8962
< Back to all news